Arévalo MFG, Badia FJJ

Idioma: Español
Referencias bibliográficas: 25
Paginas: 191-192
Archivo PDF: 32.48 Kb.

RESUMEN

La vasculitis leucocitoclásica (VL) es la más común de las vasculitis cutáneas. El envolvimiento sistémico es común usualmente, afectando sistema musculoesquelético, gastrointestinal, respiratorio, renal y nervioso periférico. Puede ser idiopática o asociada a fármacos, síndromes vasculíticos sistémicos, enfermedades autoinmunes, infecciones y neoplasias. Nosotros reportamos un caso de VL con manifestaciones clínicas severas y en el cual no se encontró una causa demostrable.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Sunderkotter C, Bonsmann G, Sindrilaru A, Lugar T. Management of leukocytoclastic vasculitis. J Dermatolog Treat 2005; 16(4): 193-206.

2. Gay M, Ball Jr, Gene. Vasculitis. In: Koopman WJ. Arthritis and Allied Conditions, a Textbook of Rheumatology. 13th Edition. William & Wilkins, 1997: 1491-1524.

3. Gonzalez EB, Conn DL. Hypersensitivity Vasculitis (Small-Vessel Cutaneous Vasculitis). In: Kelley‘s Textbook of Rheumatology. 6th Edition. W.B. Saunders Company, 2001: 1197-1203.

4. Bayer-Garner IB, Smoller BR. Leukocytoclastic (small vessel) vasculitis in multiple myeloma. Clin Exp Dermatol 2003; 28(5): 521-4.

5. Gibson LE, Su WP. Cutaneous vasculitis. Rheum Dis Clin North Am 1990; 16: 309.

6. Sams WM Jr, Thorne EG, Small P, Mass MF, McIntosh RM, Stanford RE. Leukocytoclastic vasculitis. Arch Dermatol 1976; 112(2): 219-26.

7. Doyle MK, Cuellar ML. Drug-induced vasculitis. Expert Opin Drug Saf 2003; 2(4): 401-9.

8. Mohan N, Edwards ET, Cupps TR, Slifman N, Lee JH, Siegel JN, Braun MM. Leukocytoclastic vasculitis associated with tumor necrosis factor-alpha blocking agents. J Rheumatol 2004; 31(10): 1955-8.

9. Stefan Gasser, Max Kuhn, Rudolf Speich. Severe necrotizing leucocytoclastic vasculitis in a patient taking bosentan. BMJ 2004; 329: 430 (21 August).

10. Odemis E, Kalyoncu M, Okten A, Yildiz K. Azithromycin-induced leukocytoclastic vasculitis. J Rheumatol 2003; 30(10): 2292.

11. Barksdale SK, Hallahan CW, Kerr GS, Fauci AS, Stern JB, Travis WD. Cutaneous pathology in Wegener’s granulomatosis. A clinicopathologic study of 75 biopsies in 46 patients. Am J Surg Pathol 1995; 19(2): 161-72.

12. Mangold MC, Callen JP. Cutaneous leukocytoclastic vasculitis associated with active Wegener’s granulomatosis. J Am Acad Dermatol 1992; 26(4): 579-84.

13. Ramos-Casals M, Anaya JM, Garcia-Carrasco M, Rosas J, Bove A, Claver G, Diaz LA, Herrero C, Font J. Cutaneous vasculitis in primary Sjögren syndrome: classification and clinical significance of 52 patients. Medicine (Baltimore) 2004; 83(2): 106.

14. Perez C, Guarch R, Rodrigo M, Gallego M, Ormazabal O. Successful treatment of leucocytoclastic vasculitis and pancytopenia secondary to systemic lupus erythematosus with intravenous immunoglobulin. Br J Dermatol Jul; 147(1): 180-2.

15. Sanchez-Perez J, Penas PF, Rios-Buceta L, Fernandez-Herrera J, Fraga J, Garcia-Diez A. Leukocytoclastic vasculitis in subacute cutaneous lupus erythematosus: clinicopathologic study of three cases and review of the literature. Dermatology 1996; 193(3): 230-5.

16. Magro CM, Crowson AN. The spectrum of cutaneous lesions in rheumatoid arthritis: a clinical and pathological study of 43 patients. J Cutan Pathol 2003; 30(1): 1-10.

17. Cascina A, Marone Bianco A, Mangiarotti P, Montecucco CM, Meloni F. Cutaneous vasculitis and reactive arthritis following respiratory infection due to Chlamydia pneumoniae: report of a case. Clin Exp Rheumatol 2002; 20(6): 845-7.

18. Kanai K, Kuwabara S, Mori M, Arai K, Yamamoto T, Hattori T. Leukocytoclastic-vasculitic neuropathy associated with chronic Epstein-Barr virus infection. Muscle Nerve 2003; 27(1): 113-6.

19. Cem Ar, Soysal T, Hatemi G, Salihoglu A, Yazici H, Ulku B. Successful management of cryoglobulinemia-induced leukocytoclastic vasculitis with thalidomide in a patient with multiple myeloma. Ann Hematol 2005; 84(9): 609-13.

20. Curgunlu A, Karter Y, Uvanik O, Tunckale A, Curgunlu S. Leukocytoclastic vasculitis and renal cell carcinoma. Intern Med 2004; 43(3): 256-7.

21. Lotti T, Ghersetich I, Comacchi C, Jorizzo JL. Cutaneous smallvessel vasculitis. J Am Acad Dermatol 1998; 39(5): 667-87.

22. Russell JP, Weenig RH. Primary Cutaneous Small Vessel Vasculitis. Curr Treat Options Cardiovasc Med 2004; 6(2): 139-149.

23. Fredenberg MF, Malkinson FD. Sulfone therapy in the treatment of leukocytoclastic vasculitis. Report of three cases. J Am Acad Dermatol 1987; 16(4): 772-8.

24. Sullivan TP, King LE Jr, Boyd AS. Colchicine in dermatology. J Am Acad Dermatol 1998; 39(6): 993-9.

25. Callen JP. Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1985; 13(2): 193-200.